Skip to content

Evaluation of safety and efficacy of two types of thread lift for facial rejuvenation.

Evaluation of safety, efficacy and durability of PDO thread lift- EVE & NU series (product of Meditronic Dongjun CO) for facial rejuvenation: An open label, phase 2, before- after, clinical trial.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016120720514N6
Enrollment
20
Registered
2017-11-11
Start date
2017-07-04
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

skin rejuvenation.

Interventions

Treatment - Surgery
single session inserting treated lift by a trained physician after preb and drep and local anesthesia with lidocaine.
single session inserting treated lift by a trained physician after preb and drep and local anesthesia with lidocaine

Sponsors

Aftab Froozan Arya Organization
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Male and female subjects 30-60 years old; willing to lift the face or eyebrow or improvement the nasolabial folds; providing written informed consent and attendance in follow up session. Exclusion criteria: History of any rejuvenated procedure during last years in face area; history of any Botulinum, laser, or intense pulsed light during last 6 month; history of Isotretinoin during last 3 month; collagen vascular disease; any systemic or topical disorders which interfere with process of wound healing; history of any implant in face area; severe cardiac disease or cardiac pacemaker; any active, chronic and recurrent infection; bleeding disorders, coagulopathy, any drugs affect bleeding time; susceptibility to keloids or scar formation; active smoker ( last 2 years); pregnancy/ breast feeding

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Improvement assessment using the Physician’s global assessment score. Timepoint: before and 1,3,6 months after treatment. Method of measurement: based on pictures.

Secondary

MeasureTime frame
Skin hydration. Timepoint: before and after 1,3,6 months. Method of measurement: Corneometer® - Courage - Khazaka.;Trans epidermal water loss. Timepoint: before and after 1,3,6 months. Method of measurement: Tewameter® TM 300 - Courage - Khazaka.;Depth, area and volume of wrinkle in intervention area. Timepoint: before and after 1,3,6 months. Method of measurement: VisioFace.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAniseh Samadi

Center for research and training in skin diseases and leprosy, Tehran University of Medical Sciences

aniseh_samadi@yahoo.com+98 21 8897 2220

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026